MedTrace Logo

Household Transmission Investigation Study for COVID-19 in Tropical Regions

NCT04328129 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 245

Last updated 2022-02-15

No results posted yet for this study

Summary

This study is a interventional study that present minimal risks and constraints to evaluate the presence of novel coronavirus (SARS-CoV-2) or antibodies among individuals living in households where there is a confirmed coronavirus case in order to provide useful information on the proportion of symptomatic forms and the extent of the virus transmission in tropical regions such as French Guiana, Guadeloupe and New-Caledonia.

Conditions

  • Coronavirus Infections
  • Severe Acute Respiratory Syndrome
  • SARS-CoV Infection

Interventions

PROCEDURE

Human biological samples

* Blood sample * Nasopharyngeal swab.

Sponsors & Collaborators

  • Institut Pasteur de la Guyane

    collaborator UNKNOWN

  • Centre Hospitalier Andrée Rosemon de Cayenne

    collaborator UNKNOWN

  • Institut Pasteur de la Guadeloupe

    collaborator UNKNOWN

  • Centre Hospitalier de la Guadeloupe

    collaborator UNKNOWN

  • Institut Pasteur de Nouvelle-Calédonie

    collaborator UNKNOWN

  • Centre Hospitalier Territorial de Nouvelle-Calédonie

    collaborator OTHER

  • Institut Pasteur

    lead INDUSTRY

Principal Investigators

  • Claude Flamand, PhD · Institut Pasteur de la Guyane, Head of Epidemiology Unit

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-23
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • French Guiana
  • Guadeloupe
  • New Caledonia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04328129 on ClinicalTrials.gov